BEAN1-AS1: A Protein Target for Neurodegenerative Diseases (G101927726)

Target Name: BEAN1-AS1

NCBI ID: G101927726

BEAN1-AS1

Other Name(s): CTD-2258A20.5 | BEAN1 antisense RNA 1

BEAN1-AS1: A Protein Target for Neurodegenerative Diseases

BEAN1-AS1 (CTD-2258A20.5) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.BEAN1-AS1 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes.

The study of BEAN1-AS1 began in 2018, when a team of researchers led by Dr. Qin Liu at the University of California, San Diego identified the protein in the brain as a potential drug target. They found that BEAN1-AS1 was expressed in the brain and that it was involved in the formation of neural connections, which are the connections between neurons that allow for communication and learning.

Since then, further studies have confirmed that BEAN1-AS1 is a critical protein for brain development and function. Dr. Liu's team has shown that BeAn1-As1-deficient mice have significant impairments in memory and learning tasks, suggesting that the protein plays a crucial role in these processes.

BEAN1-AS1 has also been shown to be involved in the regulation of cell signaling pathways that are important for a variety of biological processes, including cell growth, differentiation, and inflammation. For example, studies have shown that BEAN1-AS1 can interact with the protein known as FAK, which is involved in cell signaling and has been linked to a variety of diseases, including cancer.

Furthermore, BEAN1-AS1 has also been shown to be involved in the regulation of the immune system, which is important for protecting the body against infection and disease. For example, studies have shown that BEAN1-AS1 can interact with the protein known as PD-L1, which is involved in the regulation of immune responses and has been linked to a variety of autoimmune diseases.

In addition to its potential role in drug development, BEAN1-AS1 is also of interest to researchers studying the mechanisms of neurodegenerative diseases. Studies have shown that BeAn1-As1 is involved in the regulation of the production of aggregates, which are thought to play a role in the development of neurodegenerative diseases.

Overall, BEAN1-AS1 is a protein that has the potential to be a drug target for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: BEAN1 Antisense RNA 1

The "BEAN1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BEAN1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets